CORN SILK OFFERS MULTIMECHANISTIC APPROACHES IN MITIGATING OBESITY IN RODENTS
Abstract
ABSTRACT
Objective: The current study aimed to investigate the effect of corn silk extracts (aqueous and methanolic) against obesity in an animal model.
Methods: Animals were fed high-cholesterol diet (HCD) for 12 W to induce obesity and then treated either with Orlistat, corn silk extracts (aqueous and
methanolic) for 6 W. Anthropometric measurements (abdominal circumference [AC], thoracic circumference [TC], and body mass index [BMI]) were
recorded. Biochemical parameters including lipid profile (serum total cholesterol, triglycerides, low-density lipoprotein, high-density lipoprotein, and
lipase), glucose, insulin, and homeostasis model assessment of basal insulin resistance were assayed. Inflammatory cytokines visfatin, haptoglobin
(Hp), afamin, endothelin-1, calprotectin, and protein S100B levels were quantified.
Results: Significant decrease in TC, AC, and BMI was detected in HCD-fed groups treated with corn silk extracts with respect to HCD-fed group.
Biochemical analyses indicated marked hypolipidemic and hypoglycemic effects of corn silk extracts. Treatment of HCD-fed groups with corn silk
extracts experienced significant regression of visfatin, Hp, endothelin-1, calprotectin, and protein S100B levels relative to HCD-fed group.
Conclusion: In conclusion, the current findings revealed the antiobesity potential of corn silk extracts. This effect may be attributed to its hypolipidemic,
hypoglycemic, and anti-inflammatory properties of the active phytochemicals present in the extracts.
Keywords: Obesity, Corn silk, Insulin resistance, Hyperlipidemia, Inflammation, Rodents.
Downloads
References
REFERENCES
Shalaby HM, Tawfek NS, Abo-El Hussein BK, El-Ghany MS. The
assessment of some biochemical and immunological effects by
amphetamine and orlistat on obesity in rats. Food Public Health
;4(4):185-92.
Pi-Sunyer FX. The obesity epidemic: Pathophysiology and
consequences of obesity. Obes Res 2002;10 Suppl 2:97S-104.
Drew BS, Dixon AF, Dixon JB. Obesity management: Update on
orlistat. Vasc Health Risk Manag 2007;3(6):817-21.
Karamadoukis L, Shivashankar GH, Ludeman L, Williams AJ.
An unusual complication of treatment with orlistat. Clin Nephrol
;71(4):430-2.
Hasanudin K, Hashim P, Mustafa S. Corn silk (Stigma maydis) in
healthcare: A phytochemical and pharmacological review. Molecules
;17(8):9697-715.
Ebrahimzadeh MA, Pourmorad F, Hafe S. Antioxidant activities of
Iranian corn silk. Turk J Biol 2008;32:43-9.
Pietta PG. Flavonoids as antioxidants. J Nat Prod 2000;63(7):1035-42.
Hu QL, Zhang LJ, Li YN, Ding YJ, Li FL. Purification and anti-fatigue
activity of flavonoids from corn silk. Int J Phys Sci 2010;5:321-26.
Velazquez DV, Xavier HS, Batista JE, de Castro-Chaves C. Zea mays L.
extracts modify glomerular function and potassium urinary excretion in
conscious rats. Phytomedicine 2005;12(5):363-9.
Nurhanan AR, Wan Rosli WI, Mohsin S. Total polyphenol content and
free radical scavenging activity of corn silk (Zea mays hairs). Sains
Malaysiana 2012;41(10):1217-21.
Buettner R, Parhofer KG, Woenckhaus M, Wrede CE, KunzSchughart
LA,
Schölmerich J,
et
al.
Defining high-fat-diet rat
models:
Metabolic
and
molecular effects
of different
fat types. J
Mol
Endocrinol
;36(3):485-501.
Soliman MM, Attia HF, El-Shazly SA, Saleh OM. Biomedical effects
of cinnamon extract on obesity and diabetes relevance in wistar rats.
Am J Biochem Mol Biol 2012;2(3):133-45.
Nishioka T, Hafkamp AM, Havinga R, vn Lierop PP, Velvis H,
Verkade HJ. Orlistat treatment increases fecal bilirubin excretion and
decreases plasma bilirubin concentrations in hyperbilirubinemic Gunn
rats. J Pediatr 2003;143(3):327-34.
Bhaigyabati T, Ramya J, Usha K. Effect of methanolic extract of sweet
corn silk on experimentally induced hyperthyroidism in Swiss albino
rats. Int Res J Pharm 2012;3(3):241-5.
Novelli EL, Diniz YS, Galhardi CM, Ebaid GM, Rodrigues HG,
Mani F, et al. Anthropometrical parameters and markers of obesity in
rats. Lab Anim 2007;41(1):111-9.
Meiattini F, Prencipe L, Bardelli F, Giannini G, Tarli P. The
-hydroxybenzoate/4-aminophenazone chromogenic system used
in the enzymic determination of serum cholesterol. Clin Chem
;24(12):2161-5.
Bucolo G, David H. Quantitative determination of serum triglycerides
by the use of enzymes. Clin Chem 1973;19(5):476-82.
Naito HK. Cholesterol HD. Clinical Chemistry. St. Louis, Toronto,
Princeton: The C.V. Mosby Co.; 1984. p. 1207-13, 437.
Young DS. Effects of Disease on Clinical Laboratory Tests. 4
ed.
Washington, DC: AACC; 2001.
Eastham RD. Biochemical Values in Clinical Medicine. 7
ed. Bristol
England: John wright &Sons Ltd.; 1985.
Duncan MH, Singh BM, Wise PH, Carter G, Alaghband-Zadeh J.
A simple measure of insulin resistance. Lancet 1995;346(8967):120-1.
Van Vlierberghe H, Langlois M, Delanghe J. Haptoglobin
polymorphisms and iron homeostasis in health and in disease. Clin
Chim Acta 2004;345(1-2):35-42.
Armitage P, Berry G. Comparison of several groups. In: Statistical
Method in Medical Research. 2
ed. Oxford: Block well Significant
Publication; 1987. p. 186-213.
nd
Rodrigues A, Pereira PC, Vicente AF, Brito JA, Bernardo MA,
Mesquita MF. Food intake, body mass index and body fat mass in
elderly. Asian J Clin Nutr 2012;4(3):107-15.
Haslam DW, James WP. Obesity. Lancet 2005;366(9492):1197-209.
David SW. Pharmacological therapy of obesity: Past, present, and
future. J Clin Endocrinol Metab 2003;88(6):2462-9.
Devi R, Sharma DK. Hypolipidemic effect of different extracts of
Clerodendron colebrookianum Walp in normal and high-fat diet fed
rats. J Ethnopharmacol 2004;90(1):63-8.
Son EL, Pal UK, Mandal PK, Hong GE, Kim SK, Lee CH.
Hypolipidaemic effect of processed sulfur, Allium tuberosum rottl.
and fermented Allium tuberosum rottl in rat. Asian J Anim Vet Adv
;7:812-21.
Fruchart JC, Brewer HB Jr, Leitersdorf E. Consensus for the use of
fibrates in the treatment of dyslipoproteinemia and coronary heart
disease. Fibrate Consensus Group. Am J Cardiol 1998;81(7):912-7.
Raveh O, Pinchuk I, Fainaru M, Lichtenberg D. Kinetics of lipid
th
th
Asian J Pharm Clin Res, Vol 9, Issue 4, 2016, 292-298
Ahmed et al.
peroxidation in mixtures of HDL and LDL, mutual effects. Free Radic
Biol Med 2001;31(11):1486-97.
Jain PG, Patil SD, Haswani NG, Girase MV, Surana SJ. Hypolipidemic
activity of Moringa oleifera Lam., Moringaceae, on high fat diet induced
hyperlipidemia in albino rats. Braz J Pharm 2010;20(6):969-73.
Pi-Sunyer FX. A review of long-term studies evaluating the efficacy of
weight loss in ameliorating disorders associated with obesity. Clin Ther
;18(6):1006-35.
Asler IL, Zehl M, Kovacic F, Müller R, Abramic M, Allmaier G, et al.
Mass spectrometric evidence of covalently-bound tetrahydrolipstatin at
the catalytic serine of Streptomyces rimosus lipase. Biochim Biophys
Acta 2007;1770(2):163-70.
Rössner S, Sjöström L, Noack R, Meinders AE, Noseda G. Weight loss,
weight maintenance, and improved cardiovascular risk factors after
years treatment with orlistat for obesity. European Orlistat Obesity
Study Group. Obes Res 2000;8(1):49-61.
Kaup SR, Arunkumar N, Bernhardt LK, Vasari RG, Shetty SS, Pai SR,
et al. Antihyperlipedemic activity of cynodondactylon extract in highcholestrol
diet
fed wistar rats. Genom Med Biomarkers Health Sci
;3:98-102.
Weggemans RM, Trautwein EA. Relation between soy-associated
isoflavones and LDL and HDL cholesterol concentrations in humans: A
meta-analysis. Eur J Clin Nutr 2003;57(8):940-6.
Keshavarz B, Earpina S, Karki N, Losso JN. Corn Silk Bioactive
Compounds Inhibit Porcine Lipase. Conference, IFT Annual
Meeting; 2011.
Galisteo M, Sánchez M, Vera R, González M, Anguera A, Duarte J,
et al. A diet supplemented with husks of Plantago ovata reduces the
development of endothelial dysfunction, hypertension, and obesity
by affecting adiponectin and TNF-alpha in obese Zucker rats. J Nutr
;135(10):2399-404.
Ginsberg HN, Stalenhoef AF. The metabolic syndrome: Targeting
dyslipidaemia to reduce coronary risk. J Cardiovasc Risk
;10(2):121-8.
Wooding AE, Rehman I. Obesity and prostate cancer: Is there a link?
e-SPEN J 2014;9(3):123-30.
Blüher M, Michael MD, Peroni OD, Ueki K, Carter N, Kahn BB, et al.
Adipose tissue selective insulin receptor knockout protects against obesity
and obesity-related glucose intolerance. Dev Cell 2002;3(1):25-38.
Haider DG, Holzer G, Schaller G, Weghuber D, Widhalm K, Wagner O,
et al. The adipokine visfatin is markedly elevated in obese children.
J Pediatr Gastroenterol Nutr 2006;43(4):548-9.
Davutoglu M, Ozkaya M, Guler E, Garipardic M, Gursoy H,
Karabiber H, et al. Plasma visfatin concentrations in childhood obesity:
Relationships with insulin resistance and anthropometric indices. Swiss
Med Wkly 2009 10;139(1-2):22-7.
Adeghate E. Visfatin: Structure, function and relation to diabetes
mellitus and other dysfunctions. Curr Med Chem 2008;15(18):1851-62.
Jurdana M, Petelin A, Bizjak MC, Bizjak M, Biolo G, JenkoPražnikar
Z. Increased serum visfatin levels in obesity and its
association with anthropometric/biochemical parameters. Phys Inact
Nutr 2013;8(2):e59-67
Ajali U, Inya-agha SI, Odoh UE. Phytochemical and anti - Diabetic
studies of corn silk. Plant Prod Res 2007;11:16-8.
Guo J, Liu T, Han L, Liu Y. The effects of corn silk on glycaemic
metabolism. Nutr Meta 2009;6:47.
Chiellini C, Bertacca A, Novelli SE, Görgün CZ, Ciccarone A,
Giordano A, et al. Obesity modulates the expression of haptoglobin in
the white adipose tissue via TNFalpha. J Cell Physiol 2002;190(2):251-8.
Chiellini C, Santini F, Marsili A, Berti P, Bertacca A, Pelosini C, et al.
Serum haptoglobin: A novel marker of adiposity in humans. J Clin
Endocrinol Metab 2004;89(6):2678-83.
Weil BR, Westby CM, Van Guilder GP, Greiner JJ, Stauffer BL,
DeSouza CA. Enhanced endothelin-1 system activity with overweight
and obesity. Am J Physiol Heart Circ Physiol 2011;301(3):H689-95.
Traupe T, Lang M, Goettsch W, Münter K, Morawietz H, Vetter W, et al.
Obesity increases prostanoid-mediated vasoconstriction and vascular
thromboxane receptor gene expression. J Hypertens 2002;20(11):2239-45.
Ferri C, Bellini C, Desideri G, Di Francesco L, Baldoncini R,
Santucci A, et al. Plasma endothelin-1 levels in obese hypertensive and
normotensive men. Diabetes 1995;44(4):431-6.
Kronenberg F, Kollerits B, Kiechl S, Lamina C, Kedenko L,
Meisinger C, et al. Plasma concentrations of afamin are associated
with the prevalence and development of metabolic syndrome. Circ
Cardiovasc Genet 2014;7(6):822-9.
Kesh SB, Sarkar D, Manna K. High-fat diet-induced oxidative stress
and its impact on metabolic syndrome: A review. Asian J Pharm Clin
Res 2016;9(1):47-52.
Alvarez-Blasco F, MartÃnez-GarcÃa MA, Luque-RamÃrez M, Parraza N,
San Millán JL, Escobar-Morreale HF. Role of haptoglobin in polycystic
ovary syndrome (PCOS), obesity and disorders of glucose tolerance in
premenopausal women. PLoS One 2009;4(5):e5606.
Habtemariam S. Extract of corn silk (stigma of Zea mays) inhibits the
tumour necrosis factor-alpha- and bacterial lipopolysaccharide-induced
cell adhesion and ICAM-1 expression. Planta Med 1998;64(4):314-8.
Francischetti EA, Genelhu VA. Obesity-hypertension: An ongoing
pandemic. Int J Clin Pract 2007;61(4):269-80.
Suzuki R, Iijima M, Okada Y, Okuyama T. Chemical constituents of the
style of Zea mays L. with glycation inhibitory activity. Chem Pharm
Bull (Tokyo) 2007;55(1):153-5.
Mortensen OH, Nielsen AR, Erikstrup C, Plomgaard P, Fischer CP,
Krogh-Madsen R, et al. Calprotectin – A novel marker of obesity. PLoS
One 2009;4(10):e7419.
Manitz MP, Horst B, Seeliger S, Strey A, Skryabin BV, Gunzer M, et al.
Loss of S100A9 (MRP14) results in reduced interleukin-8-induced
CD11b surface expression, a polarized microfilament system, and
diminished responsiveness to chemoattractants in vitro. Mol Cell Biol
;23(3):1034-43.
RodrÃguez A, Catalán V, Gómez-Ambrosi J, Frühbeck G. Visceral
and subcutaneous adiposity: Are both potential therapeutic
targets for tackling the metabolic syndrome? Curr Pharm Des
;13(21):2169-75.
Catalán V, Gómez-Ambrosi J, RodrÃguez A, RamÃrez B, Rotellar F,
Valentà V, et al. Increased levels of calprotectin in obesity are related to
macrophage content: Impact on inflammation and effect of weight loss.
Mol Med 2011;17(11-12):1157-67.
Fujiya A, Nagasaki H, Seino Y, Okawa T, Kato J, Fukami A, et al. The
role of S100B in the interaction between adipocytes and macrophages.
Obesity (Silver Spring) 2014;22(2):371-9.
Steiner J, Schiltz K, Walter M, Wunderlich MT, Keilhoff G,
Brisch R, et al. S100B serum levels are closely correlated with
body mass index: An important caveat in neuropsychiatric research.
Psychoneuroendocrinology 2010;35(2):321-4.
Buckman LB, Anderson-Baucum EK, Hasty AH, Ellacott KLj.
Regulation of S100B in white adipose tissue by obesity in mice.
Adipocyte 2014;3(3):215-20.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.